MedPath

PADAGIS LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Safety Study of Entocort for Children With Crohn's Disease

Phase 3
Completed
Conditions
Crohn's Disease
Interventions
First Posted Date
2011-09-30
Last Posted Date
2022-01-06
Lead Sponsor
Padagis LLC
Target Recruit Count
123
Registration Number
NCT01444092
Locations
🇵🇱

Research Site, Łódź, Poland

Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels

First Posted Date
2010-06-07
Last Posted Date
2021-10-13
Lead Sponsor
Padagis LLC
Target Recruit Count
1555
Registration Number
NCT01138514

Clinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations

Not Applicable
Completed
Conditions
Acne Vulgaris
Interventions
Drug: 1% Clindamycin/5% Benzoyl Peroxide Topical Gel
Drug: Placebo
First Posted Date
2010-01-07
Last Posted Date
2023-07-12
Lead Sponsor
Padagis LLC
Target Recruit Count
602
Registration Number
NCT01044264

A Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% Formulations

Not Applicable
Completed
Conditions
Vulvovaginal Candidiasis
Interventions
Drug: Gynazole 1 vaginal cream
Drug: Placebo
First Posted Date
2009-12-25
Last Posted Date
2023-07-12
Lead Sponsor
Padagis LLC
Target Recruit Count
611
Registration Number
NCT01039584
Locations
🇺🇸

PharmaNet, Inc. (PharmaNet), Charlotte, North Carolina, United States

Bioavailability of Prochlorperazine Suppositories, 25 mg

First Posted Date
2009-10-09
Last Posted Date
2021-10-21
Lead Sponsor
Padagis LLC
Target Recruit Count
42
Registration Number
NCT00992472
Locations
🇺🇸

PharmaKinetics Laboratories, Inc, Baltimore, Maryland, United States

A Relative Bioavailability Study of 100 mg Flavoxate Hydrochloride Tablets Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Urispas® Tablets, 100mg
First Posted Date
2009-10-09
Last Posted Date
2023-07-10
Lead Sponsor
Padagis LLC
Target Recruit Count
48
Registration Number
NCT00992238
Locations
🇺🇸

PRACS Institute, Ltd, Fargo, North Dakota, United States

Safety and Equivalence of a Terconazole Vaginal Suppository (Test Product) Compared to the Reference Terconazole Vaginal Suppository in the Treatment of Vulvovaginal Candidiasis

Not Applicable
Completed
Conditions
Vulvovaginal Candidiasis
Interventions
Drug: Terazol Vaginal Suppository
First Posted Date
2008-12-08
Last Posted Date
2021-10-13
Lead Sponsor
Padagis LLC
Target Recruit Count
572
Registration Number
NCT00803738

Randomized Study to Compare the Bioavailability of Two Clobetasol Propionate 0.05% Topical Foams

First Posted Date
2008-12-05
Last Posted Date
2021-10-15
Lead Sponsor
Padagis LLC
Target Recruit Count
80
Registration Number
NCT00803439
© Copyright 2025. All Rights Reserved by MedPath